Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy.
Frisch AT, Wang Y, Xie B, Yang A, Ford BR, Joshi S, Kedziora KM, Peralta R, Wilfahrt D, Mullett SJ, Spahr K, Lontos K, Jana JA, Dean VG, Gunn WG, Gelhaus S, Poholek AC, Rivadeneira DB, Delgoffe GM.
Frisch AT, et al. Among authors: xie b.
Cell Metab. 2025 Jan 24:S1550-4131(24)00489-3. doi: 10.1016/j.cmet.2024.12.007. Online ahead of print.
Cell Metab. 2025.
PMID: 39879981